FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

703146007: Ceritinib (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3007506010 Ceritinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3007670012 Ceritinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
369131000195118 ceritinib it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799381000172110 céritinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ceritinib Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Ceritinib Is a Antineoplastic agent (substance) true Inferred relationship Some
Ceritinib This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Ceritinib Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Ceritinib Is a Enzyme inhibitor false Inferred relationship Some
Ceritinib Is a Sulfone (substance) true Inferred relationship Some
Ceritinib Is a Piperidine true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ceritinib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ceritinib Inferred relationship Some 1
Product containing precisely ceritinib 150 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ceritinib Inferred relationship Some
Product containing precisely ceritinib 150 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ceritinib Inferred relationship Some 1
Product containing precisely ceritinib 150 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ceritinib Inferred relationship Some 1
Product containing precisely ceritinib 150 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ceritinib Inferred relationship Some 1
Product containing ceritinib in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ceritinib Inferred relationship Some 1
Product containing only ceritinib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ceritinib Inferred relationship Some 1
Ceritinib only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ceritinib Inferred relationship Some 1
Ceritinib 150 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ceritinib Inferred relationship Some 1
Ceritinib 150 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ceritinib Inferred relationship Some 1

This concept is not in any reference sets

Back to Start